SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifungal, anti-convulsant, anti-emetic, ophthalmic, anti-worm, and antiemetic. It also exports its products. The company was founded in 1990 and is based in Hyderabad, India.
Stock data | 2023 | Change |
---|---|---|
Price | $18.85 | N/A |
Market Cap | $57.00M | N/A |
Shares Outstanding | 3.02M | 0.00% |
Employees | 567.00 | N/A |
Shareholder Equity | 1.88B | 14.12% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.50 | N/A |
P/S Ratio | 1.53 | N/A |
P/B Ratio | 0.03 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0007 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $37.26M | N/A |
Earnings | $1.36M | N/A |
EPS | 37.92 | N/A |
Earnings Yield | 2.01 | N/A |
Gross Margin | 0.2705 | N/A |
Operating Margin | 0.0577 | N/A |
Net income margin | 0.0364 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $47.08M | N/A |
Total Debt | $11.98M | N/A |
Cash on Hand | $430.34K | N/A |
Debt to Equity | 0.0131 | -5.59% |
Cash to Debt | 0.0359 | -14.79% |
Current Ratio | $1.19 | 3.42% |